Cite
Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans.
MLA
Sommer, Christine, et al. “Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans.” The Journal of Clinical Endocrinology and Metabolism, vol. 108, no. 5, Apr. 2023, pp. 1110–19. EBSCOhost, https://doi.org/10.1210/clinem/dgac699.
APA
Sommer, C., Vangberg, K. G., Moen, G.-H., Evans, D. M., Lee-Ødegård, S., Blom-Høgestøl, I. K., Sletner, L., Jenum, A. K., Drevon, C. A., Gulseth, H. L., & Birkeland, K. I. (2023). Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans. The Journal of Clinical Endocrinology and Metabolism, 108(5), 1110–1119. https://doi.org/10.1210/clinem/dgac699
Chicago
Sommer, Christine, Kjersti G Vangberg, Gunn-Helen Moen, David M Evans, Sindre Lee-Ødegård, Ingvild K Blom-Høgestøl, Line Sletner, et al. 2023. “Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans.” The Journal of Clinical Endocrinology and Metabolism 108 (5): 1110–19. doi:10.1210/clinem/dgac699.